Form4insider filings, from the source

SEC Form 4 · accession 0001664281-26-000002

Entrada Therapeutics, Inc. · TRDA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kush Parmar
Director · 10% Owner
Period of report
Jul 30, 2026
Accepted (ET)
Aug 3, 2026 · 5:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001689375

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jul 30, 2026S114,756$6.93D2,848,310IBy 5AM Ventures V, L.P.
Common StockJul 31, 2026S1,718$6.85D2,846,592IBy 5AM Ventures V, L.P.
Common StockF3holding———1,093,313IBy 5AM Opportunities I, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses